Development of the shortness of breath with daily activities questionnaire (SOBDA)

Value in Health

Volumn 15, Issue 8, 2012, Pages 1042-1050

  Howard, Kellee ^a   Berry, Pamela ^b   Petrillo, Jennifer ^c   Wiklund, Ingela ^a   Roberts, Laurie ^a   Watkins, Michael ^d   Crim, Courtney ^d   Wilcox, Teresa ^a  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c NOVARTIS PHARMA AG   (Switzerland)

^d GLAXOSMITHKLINE   (United States)

Author keywords

COPD; patient reported outcomes; qualitative research; quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DAILY LIFE ACTIVITY; DYSPNEA; FEEDBACK SYSTEM; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; INTERVIEW; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUESTIONNAIRE; SHORTNESS OF BREATH WITH DAILY ACTIVITIES QUESTIONNAIRE; WHEEZING;

AGED; DYSPNEA; FEMALE; FOCUS GROUPS; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITATIVE RESEARCH; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SOCIOECONOMIC FACTORS;

EID: 84871213474     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.06.018     Document Type: Article

References (46)

1. GOLD: Global Strategy for the Diagnosis, Management, and Prevention of COPD - updated 2011. Available from: http://www.goldcopd.org. [Accessed May 23, 2012].
2. K. Nishimura, T. Izumi, M. Tsukino, and T. Oga Dyspnea is a better predictor of 5-year survival than airway obstruction in patients Chest 121 2002 1434 1440 (Pubitemid 34499652)
3. P.W. Jones, and A.G. Agusti Outcomes and markers in the assessment of chronic obstructive pulmonary disease Eur Respir J 27 2006 822 832 (Pubitemid 44914209)
4. J. Vestbo, W. Anderson, and H.O. Coxson Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Eur Respir J 31 2008 869 873
5. M.K. Han, A. Agusti, and P.M. Calverley Chronic obstructive pulmonary disease phenotypes: the future of COPD Am J Respir Crit Care Med 182 2010 598 604
6. A. Jadad, C. Rizo, P. Cubillos, and E. Stahl Measuring symptom response to pharmacological interventions in patients with COPD: a review of instruments used in clinical trials Curr Med Res Opin 20 2004 1993 2005 (Pubitemid 40179638)
7. E.G. Eakin, P.M. Resnikoff, and L.M. Prewitt Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California San Diego. Chest 113 1998 619 624 (Pubitemid 28130933)
8. S.F. Ho, M.S. O'Mahony, and J.A. Steward Dyspnoea and quality of life in older people at home Age Ageing 30 2001 155 159 (Pubitemid 32492612)
9. C.J. Jolley, and J. Moxham A physiological model of patient-reported breathlessness during daily activities in COPD Eur Respir Rev 18 2009 66 79
10. H. Watz, B. Waschki, T. Meyer, and H. Magnussen Physical activity in patients with COPD Eur Respir J 33 2009 262 272
11. B.R. Celli, and W. MacNee Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur Resp J 23 2004 932 946 (Pubitemid 38807371)
12. D.E. Victorson, S. Anton, and A. Hamilton A conceptual model of the experience of dyspnea and functional limitations in chronic obstructive pulmonary disease Value Health 12 2009 1018 1025
13. Food and Drug Administration. Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. 2009. Available from: www.fda.gov. [Accessed May 23, 2012].
14. N. Krieger Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology Am J Public Health 82 1992 703 710
15. D.L. Patrick, L.B. Burke, and J.H. Powers Patient-reported outcomes to support medical product labeling claims: FDA perspective Value Health 10 Suppl 2007 S125 S137 (Pubitemid 350098929)
16. G. Guest, A. Bunce, and L. Johnson How many interviews are enough? An experiment with data saturation and variability Field Methods 18 2006 59 82
17. N.K. Leidy, and M. Vernon Perspectives on patient-reported outcomes: content validity and qualitative research in a changing clinical trial environment Value Health 10 Suppl. 2 2007 S125 S137
18. D.L. Patrick, L.B. Burke, and C.J. Gwaltney Content validity-establishing and reporting the evidence in newly developed Patient-Reported Outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force Report: part 1-eliciting concepts for a new PRO instrument Value Health 14 2011 967 977
19. R.S.F. Schilling, J.P.W. Hughes, and I. Dingwall-Fordyce Disagreement between observers in an epidemiological study of respiratory disease BMJ 1 1955 65 68
20. P.W. Jones, F.H. Quirk, and C.M. Baveystock The St. George's Respiratory Questionnaire Respir Med 85 Suppl. B 1991 25 31
21. P.W. Jones, F.H. Quirk, C.M. Baveystock, and P. Littlejohns A self-complete measure of health status for chronic airflow limitation: The St George's Respiratory Questionnaire Ann Rev Respir Dis 145 1992 1321 1327
22. S.D. Aaron, K.L. Vandemheen, and P. Hebert Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease N Engl J Med 348 2003 2618 2625 (Pubitemid 36741589)
23. S.D. Aaron, K.L. Vandemheen, and J.J. Clinch Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation Chest 121 2002 688 696 (Pubitemid 34251429)
24. C.M. Parker, N. Voduc, and S.D. Aaron Physiological changes during symptom recovery from moderate exacerbations of COPD Eur Respir J 26 2005 420 428 (Pubitemid 41264203)
25. D. Wild, A. Grove, and M. Martin Principles of good practice for the translation and cultural adaptation process for patient reported outcome (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation Value Health 8 2005 94 104 (Pubitemid 40525371)
26. S.J. Coons, C.J. Gwaltney, and R.D. Hays Recommendations of evidence needed to support measurement of equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force Report Value Health 12 2009 410 429
27. R. Likert A technique for the measurement of attitudes Arch Psychol 140 1932 1 55
28. T. Muhr User's Manual for ATLAS.ti 5.0 (2nd ed.). Copyright © 2003-2004 by Tomas Muhr 2004 ATLAS.ti scientific Software Development Berlin
29. V.K. Carrieri, S. Janson-Bjerklie, and S. Jacobs The sensation of dyspnea: a review Heart Lung 13 1984 436 447
30. V. Carrieri-Kohlman, J.M. Gormley, and S. Eiser Dyspnea and the affective response during exercise training in obstructive pulmonary disease Nurs Res 50 2001 136 146 (Pubitemid 33603801)
31. A.J. DeVito Dyspnea during hospitalizations for acute phase of illness as recalled by patients with chronic obstructive pulmonary disease Heart Lung 19 1990 186 191
32. A.G. Gift, T. Moore, and K. Soeken Relaxation to reduce dyspnea and anxiety in COPD patients Nurs Res 41 1992 242 246
33. S. Lareau, and J.L. Larson Ineffective breathing pattern related to airflow limitation Nurs Clin North Am 22 1987 179 191 (Pubitemid 17065540)
34. D.A. Mahler, R. Mejia-Alfaro, J. Ward, and J.C. Baird Continuous measurement of breathlessness during exercise: validity, reliability, and responsiveness J Appl Physiol 90 2001 2188 2196 (Pubitemid 32467411)
35. S. Small, and M. Lamb Fatigue in chronic illness: the experience of individuals with chronic obstructive pulmonary disease and with asthma J Adv Nurs 30 1999 469 478
36. K. Wasserman, and R. Casaburi Dyspnea: physiological and pathophysiological mechanisms Annu Rev Med 39 1988 503 515 (Pubitemid 19090817)
37. A. von Leupoldt, and B. Dahme Psychological aspects in the perception of dyspnea in obstructive pulmonary diseases Respir Med 101 2007 411 422 (Pubitemid 46196319)
38. V. Carrieri-Kohlman, D. Donesky-Cuenco, and S.K. Park Additional evidence for the affective dimension of dyspnea in patients with COPD Res Nurs Health 33 2010 4 19
39. K. Hill, R. Geist, R.S. Goldstein, and Y. Lacasse Anxiety and depression in end-stage COPD Eur Respir J 31 2008 667 677
40. H.Q. Nguyen, and V. Carrieri-Kohlman Dyspnea self-management in patients with chronic obstructive pulmonary disease: moderating effects of depressed mood Psychosomatics 46 2005 402 410 (Pubitemid 46173199)
41. R. Norwood, and R. Balkissoon Current perspectives on management of co-morbid depression in COPD COPD 2 2005 185 193 (Pubitemid 40776240)
42. L.C. Elofsson, and J. Ohlen Meanings of being old and living with chronic obstructive pulmonary disease Palliat Med 18 2004 611 618 (Pubitemid 39468108)
43. M. Barnett Chronic obstructive pulmonary disease: a phenomenological study of patients' experiences J Clin Nurs 14 2005 805 812 (Pubitemid 41018436)
44. D.A. Nicholls The experience of breathlessness Physiother Theory Pract 19 2003 123 136
45. H. Jonsdottir Life patterns of people with chronic obstructive pulmonary disease: isolation and being closed in Nurs Sci Q 11 1998 160 166 (Pubitemid 128685429)
46. N.K. Leidy, and M. Vernon Perspectives on patient-reported outcomes: content validity and qualitative research in a changing clinical trial environment Pharmacoeconomics 26 5 2008 363 370 (Pubitemid 351572050)